⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21784585 | 0.88 | — | — | |
| SCHEMBL22759827 | 0.88 | — | — | |
| SCHEMBL21780521 | 0.82 | — | — | |
| SCHEMBL23426176 | 0.79 | — | — | |
| SCHEMBL24272199 | 0.79 | — | — | |
| SCHEMBL31061886 | 0.77 | — | — | |
| SCHEMBL19341339 | 0.77 | — | — | |
| SCHEMBL14752760 | 0.76 | CACNA1G (0.32) | — | |
| SCHEMBL22650305 | 0.76 | CACNA1G (0.32) | — | |
| SCHEMBL27429053 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200071322-A1 | INHIBITING (ALPHA-V)(BETA-6) INTEGRIN | MORPHIC THERAPEUTIC, INC. | 2020-03-05 | — | — | US | disclosed |